Table 2.

Duration of meropenem and concomitant antimicrobial therapy

	Standard-dose meropenem (n = 38)	High-dose meropenem (n = 38)	P value
Day of meropenem therapy, median (IQR)	6 (3–16)	5 (3–21)	0.035*
Concomitant antimicrobial therapy, n (%)	16 (42.1)	19 (50)	0.646
Colistin, n (%)	3 (18.8)	2 (10.5)	0.642
Vancomycin, n (%)	7 (43.8)	6 (31.6)	0.503
Cotrimoxazole, n (%)	1 (6.3)	4 (21.1)	0.347
Levofloxacin, n (%)	0 (0)	3 (15.8)	0.234
Amikacin, n (%)	4 (25)	3 (15.8)	0.677
Azithromycin, n (%)	1 (6.3)	2 (10.5)	1.000
Oseltamivir, n (%)	2 (12.5)	2 (10.5)	1.000
De-escalation, n (%)	21 (55.3)	25 (65.8)	0.436

*Statistically significant difference